Carbamazepine induced secondary hyperparathyroidism: A rare clinical entity

Abstract

Antiepileptic drugs (AEDs) are associated with altered bone metabolism and decreased bone density thereby increasing the risk of fractures several folds. This is a unique case report of a young 34 year old female diagnosed as a case of partial epilepsy two years back, was on carbamazepine (CBZ) therapy (300 mg SR twice a day). The seizures were fully controlled but she presented with gradual pure motor weakness involving proximal muscles over the duration of one year. There was a pentad of weakness, raised alkaline phosphatase (ALP), hypocalcaemia, hypophosphatemia and raised parathyroid hormone PTH. On dechallenge by tapering the doses of carbamazepine and starting newer antiepileptic there was marked improvement in the weakness. It has been found that epilepsy itself increases the risk of seizures and also anti-epileptics alter the bone metabolism by various mechanisms. Therefore while starting the antiepileptic in young patients for long term, high levels of suspicion should be kept in mind in view of altered calcium metabolism and even the first sign should not be missed. This patient presented with inability to walk and on evaluation was found to have secondary hyperparathyroidism. The pentad of weakness, raised ALP, hypocalcaemia and increased PTH in a patient on carbemazapine can easily lead to diagnosis.

Authors and Affiliations

Tarun Sharma, Aradhna Sharma, Dinesh Kansal, Himani Prajapati

Keywords

Related Articles

Polyvalent Anti Snake Venom: Adverse drug reactions in children

Snakebite is one of the important causes of mortality in our country. Anti-snake venom (ASV) is administered in the management of snake bite. In India polyvalent ASV is used. There is risk of anaphylactic reaction. It sh...

Pharmacokinetic interaction of Phosphorus on the treatment of sputum positive pulmonary tuberculosis patients

Tuberculosis (TB) in children is a neglected aspect of the TB epidemic despite it constituting 20% or more of all TB cases in many countries with high TB incidence. Tuberculosis constitutes a serious global health proble...

Are we missing tracks while prescribing proton pump inhibitors? - An opinion from clinicians cross sectional hospital based questionnaire study

Introduction Poton pump inhibitors are the main stage standard therapy for various gastrointestinal disorders such as upper gastrointestinal disorders GERD dyspepsia and peptic ulcer disease1 The availability of PPIs as...

Clinical comparison of Annabedi Chendhuram (siddha system of medicine) and elemental iron in the treatment of iron deficiency anaemia

Introduction Healthy human body needs iron for multiple process during development Several diseases are associated with iron deficiency and increased demands also may lead to iron deficiency Many diseases have been addre...

A cross-sectional study of patterns of adverse drug reactions reported in the department of pharmacology of a tertiary care teaching hospital in North East India

Introduction: Adverse Drug Reactions (ADRs) are a great cause of concern to the general public, medical profession, the patients and the pharmaceutical industry. For this reason Pharmacovigilance, which is an evolving sc...

Download PDF file
  • EP ID EP319299
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

Tarun Sharma, Aradhna Sharma, Dinesh Kansal, Himani Prajapati (2017). Carbamazepine induced secondary hyperparathyroidism: A rare clinical entity. IP International Journal of Comprehensive and Advanced Pharmacology, 2(2), 68-69. https://europub.co.uk./articles/-A-319299